Actively Recruiting
Histiocytic Disorder Follow-up Study
Led by University of Alabama at Birmingham · Updated on 2025-06-11
6000
Participants Needed
1
Research Sites
326 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to describe the burden of chronic health conditions, psychological dysfunction, chronic pain, healthcare utilization, worse health-related quality of life, overall mortality, and cause-specific mortality among individuals with histiocytic disorders
CONDITIONS
Official Title
Histiocytic Disorder Follow-up Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of any histiocytic disorder at any age
- Includes Langerhans cell histiocytosis
- Includes Erdheim-Chester disease
- Includes Rosai-Dorfman disease
- Includes Xanthogranuloma
- Includes mixed histiocytosis
- Includes malignant histiocytosis such as histiocytic sarcoma, langerhans cell sarcoma, interdigitating cell sarcoma
- Includes hemophagocytic lymphohistiocytosis
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
Actively Recruiting
Research Team
G
Gaurav Goyal, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here